WALVAX BIOTECHNOLO revenue breakdown overview

WALVAX BIOTECHNOLO revenue for the last year amounted to 2.82 B CNY, the most of which — 2.54 B CNY — came from its highest performing source at the moment, Autonomous Vaccine, the year earlier bringing 4.08 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought WALVAX BIOTECHNOLO 2.25 B CNY, and the year before that — 3.83 B CNY.